Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 93 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Anastasilakis, Athanasios D  [Clear All Filters]
2013
Anastasilakis, A. D., Ruggeri R-M., Polyzos S. A., Makras P., Molyva D., Campennì A., et al. (2013).  Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.. Metabolism. 62(10), 1350-6.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Bisbinas I., Gerou S., & Makras P. (2013).  Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.. J Clin Endocrinol Metab. 98(8), 3206-12.
Sakellariou, G. T., Sayegh F. E., Anastasilakis A. D., & Kapetanos G. A. (2013).  Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.. Rheumatol Int. 33(11), 2917-20.
Makras, P., Polyzos S. A., Papatheodorou A., Kokkoris P., Chatzifotiadis D., & Anastasilakis A. D. (2013).  Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis.. Clin Endocrinol (Oxf). 79(4), 499-503.
Gkiomisi, A., Makedou K. G., Anastasilakis A. D., Polyzos S. A., Kourtis A., Gerou S., et al. (2013).  Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum.. Cytokine. 61(1), 127-32.
2012
Anastasilakis, A. D., Polyzos S. A., Makras P., Sakellariou G. T., Bisbinas I., Gkiomisi A., et al. (2012).  Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.. Bone. 50(5), 1130-4.
Polyzos, S. A., Anastasilakis A. D., & Arsos G. (2012).  Acute transient thyroid swelling following needle biopsy: an update.. Hormones (Athens). 11(2), 147-50.
Anastasilakis, A. D., Toulis K. A., Polyzos S. A., Anastasilakis C. D., & Makras P. (2012).  Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab.. Ther Clin Risk Manag. 8, 295-306.
Polyzos, S. A., Anastasilakis A. D., Anagnostis P., Kita M., Arsos G., Moralidis E., et al. (2012).  Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.. Endokrynol Pol. 63(4), 312-5.
Anastasilakis, A. D., Polyzos S. A., Makras P., Kampas L., Valeri R. Maria, Kyriakoulis D., et al. (2012).  Papillary thyroid microcarcinoma presenting as lymph node metastasis--a diagnostic challenge: case report and systematic review of literature.. Hormones (Athens). 11(4), 419-27.
Anastasilakis, A. D., Polyzos S. A., Delaroudis S., Bisbinas I., Sakellariou G. T., Gkiomisi A., et al. (2012).  The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.. Clin Endocrinol (Oxf). 77(6), 816-22.
Makras, P., Polyzos S. A., Anastasilakis A. D., Terpos E., Papatheodorou A., & Kaltsas G. A. (2012).  Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?. Mol Ther. 20(1), 6-7.
Makras, P., Polyzos S. A., Anastasilakis A. D., Terpos E., Kanakis G., Schini M., et al. (2012).  Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis.. J Clin Endocrinol Metab. 97(4), E618-21.
2011
Kourtis, A., Gkiomisi A., Mouzaki M., Makedou K., Anastasilakis A. D., Toulis K. A., et al. (2011).  Apelin levels in normal pregnancy.. Clin Endocrinol (Oxf). 75(3), 367-71.
Anastasilakis, A. D., Polyzos S. A., Anastasilakis C. D., Toulis K. A., & Makras P. (2011).  Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis.. Med Hypotheses. 77(1), 109-11.
Makras, P., Anastasilakis A. D., Polyzos S. A., Bisbinas I., Sakellariou G. T., & Papapoulos S. E. (2011).  No effect of rosuvastatin in the zoledronate-induced acute-phase response.. Calcif Tissue Int. 88(5), 402-8.
Makedou, K., Kourtis A., Gkiomisi A., Toulis K. A., Mouzaki M., Anastasilakis A. D., et al. (2011).  Oxidized low-density lipoprotein and adiponectin levels in pregnancy.. Gynecol Endocrinol. 27(12), 1070-3.
Anastasilakis, A. D., Polyzos S. A., & Toulis K. A. (2011).  Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.. Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
Giomisi, A., Kourtis A., Toulis K. A., Anastasilakis A. D., Makedou K. G., Mouzaki M., et al. (2011).  Serum vaspin levels in normal pregnancy in comparison with non-pregnant women.. Eur J Endocrinol. 164(4), 579-83.
Toulis, K. A., Anastasilakis A. D., Polyzos S. A., & Makras P. (2011).  Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis.. Hormones (Athens). 10(3), 174-95.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.